HGF and neoplasm: Nevertheless, none of these factors showed significant changes from baseline to best tumor response (ANGPTL4, 2.9 to 3.9 ng/mL, p = 0.16; HGF, 0.79 to 0.75 ng/mL, P = 0.60; VEGF-A121, 0.60 to 0.39 ng/mL, P = 0.26).